Caleb Freeman, MD
Assistant Professor, Dermatology
Medical School
- MD, Creighton University School of Medicine (2020)
Undergraduate School
- AS, Utah Valley University (UT) (2009)
- BS, Brigham Young University (UT) (2015)
Internship
- St Vincent's Medical Center Program (2021)
Residency
- Oregon Health & Science University, Chief Resident, Dermatology (2024)
Fellowships
- University of Pennsylvania Health System Program, Mohs Surgery (2025)
Languages
English, Croatian, Bosnian, SerbianDepartment
DermatologyProfessional Titles
- Mohs Micrographic and Reconstructive Surgeon
- Pigmented Lesion Specialist
Recognitions
- Dermatology Fellowship Award, Melanoma Research Alliance (2022)
- 1st Place Award for Medical Student Research, Creighton University Medical Center, Department of Medicine (2019)
- Carolyn L. Kuckein Student Research Fellowship, Alpha Omega Alpha Honor Medical Society (2017)
Research Interests
I have led several research projects focused on the early detection of melanoma and the improvement of surgical treatments for melanoma, which inform my clinical practice and help me to provide the highest level of care for my patients. I have been invited to speak at the American College of Mohs Surgery and the American Society for Dermatologic Surgery.Publications
- Roland-McGowan JN, Freeman SC, Baghoomian W, Carroll BT, Kim CC, Curiel-Lewandrowski C, Chu EY, Foster EL, Nelson KC, White KP, Ming ME, Hartman RI, Leachman SA, Mengden-Koon S, Chen SC, Swetter SM, Prieto VG, Berry E, Yu WY. Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision. J Am Acad Dermatol. 2025 May;92(5):1112-1114. PubMed PMID: 39827941
- Freeman SC, Paz Munoz E, Latour E, Lim JY, Yu W. Response to Prieto et al, "RE: External validation of the Melanoma Institute Australia sentinel lymph metastasis risk prediction tool using the National Cancer Database". J Am Acad Dermatol. 2024 Sep;91(3):e75-e76. PubMed PMID: 38740332
- Seervai RNH, Munoz EP, Freeman SC, Swords RI, White KP, Keller JJ. Sweet's syndrome associated with FLT3 inhibition. JAAD Case Rep. 2024 Dec;54:89-92. PubMed PMID: 39687070
- Haroon A, Freeman SC, Heath MS, Leitenberger JJ. Repair of a Multi-subunit Defect on the Nose and Apical Triangle Following Mohs Micrographic Surgery. Dermatol Surg. 2024 Oct 28. [Epub ahead of print] PubMed PMID: 39465682
- Freeman SC, Dacy NN, Neill BC, Chisholm C, Tolkachjov SN. Intraneural Melanoma Identified With MART-1 Immunostaining in Mohs Micrographic Surgery. Cureus. 2024 Apr;16(4):e58920. PubMed PMID: 38800274
- Freeman SC, Neill B, Garvey C, Leitenberger JJ. Bilateral Transposition Flaps With Split-Thickness Skin Grafting of Secondary Defects After a Large Mohs Micrographic Surgery Defect With Exposed Calvarium. Cureus. 2023 Jul;15(7):e42191. PubMed PMID: 37602082
- Freeman SC, Paz Munoz E, Latour E, Lim JY, Yu W. External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database. J Am Acad Dermatol. 2023 Nov;89(5):967-973. PubMed PMID: 37454700
- Young JN, Nguyen TA, Freeman SC, Hill E, Johnson M, Gharavi N, Bar A, Leitenberger J. Permanent section margin concordance after Mohs micrographic surgery with immunohistochemistry for invasive melanoma and melanoma in situ: A retrospective dual-center analysis. J Am Acad Dermatol. 2023 May;88(5):1060-1065. PubMed PMID: 36720365
- Freeman SC, Heath MS, Neill B, Morris C, Lucero OM, Yu W, Bar A, Leitenberger JJ. Tranexamic Acid Prevention of Hemorrhagic Complications Following Interpolated Flap Repair: A Single-Center, Retrospective, Cohort Study. Dermatol Surg. 2023 Dec 1;49(12):1139-1142. PubMed PMID: 37712760
- Trepanowski N, Chang MS, Zhou G, Ahmad M, Berry EG, Bui K, Butler WH, Chu EY, Curiel-Lewandrowski C, Dellalana LE, Ellis DL, Freeman SC, Gorrepati PL, Grossman D, Gyurdzhyan S, Kanetsky PA, King ALO, Kolla AM, Lian CG, Lin JY, Liu V, Lowenthal A, McCoy KN, Munjal A, Myrdal CN, Perkins S, Powers JG, Rauck C, Smart TC, Stein JA, Venna S, Walsh ME, Wang JY, Leachman SA, Swetter SM, Hartman RI. Delays in melanoma presentation during the COVID-19 pandemic: A nationwide multi-institutional cohort study. J Am Acad Dermatol. 2022 Nov;87(5):1217-1219. PubMed PMID: 35738513
- Blue ED, Freeman SC, Lobl MB, Clarey DD, Fredrick RL, Wysong A, Whitley MJ. Cutaneous Squamous Cell Carcinoma Arising in Immunosuppressed Patients: A Systematic Review of Tumor Profiling Studies. JID Innov. 2022 Jul;2(4):100126. PubMed PMID: 35620703
- Freeman SC, Dick MK, Abid R, Tabatabai TM, Berrebi KG, Stone MS, Powers JG. A case of idiopathic acquired leukonychia totalis in a 17-year-old boy. Pediatr Dermatol. 2021 Mar;38(2):477-480. PubMed PMID: 33534174
- Freeman SC, Satish M, Walters RW. Comorbidity burden on receipt of adjuvant immunotherapy and survival in patients with stage III melanoma: an analysis of the National Cancer Database. Int J Dermatol. 2020 Nov;59(11):1381-1390. PubMed PMID: 32592609
- Arce Gastelum A, Volberding T, Freeman SC, Dick M, Gbadamosi-Akindele M. Procalcitonin Perplexity - Prolonged Idiopathic Elevation in Pleomorphic Sarcoma: A Case Report and Review of the Literature. Cureus. 2020 May 20;12(5):e8215. PubMed PMID: 32582476
- Freeman C, Hull C, Sontheimer R, Curtis J. Squamous cell carcinoma of the dorsal hands and feet after repeated exposure to ultraviolet nail lamps. Dermatol Online J. 2020 Mar 15;26(3). PubMed PMID: 32609442
- Freeman SC, Baskaran J, Gbadamosi-Akindele M. Human Herpesvirus-8 Negative Multicentric Castleman Disease in a Patient with Human Immunodeficiency Virus Treated with Highly Active Antiretroviral Therapy and Chemotherapy. Cureus. 2019 Aug 30;11(8):e5530. PubMed PMID: 31523587
- Ludwig PE, Freeman SC, Janot AC. Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa. Int J Retina Vitreous. 2019;5:7. PubMed PMID: 30805203
- Al-Matouq J, Holmes T, Hammiller B, Tran N, Holmes M, Freeman SC, Hansen LA. Accumulation of cytoplasmic CDC25A in cutaneous squamous cell carcinoma leads to a dependency on CDC25A for cancer cell survival and tumor growth. Cancer Lett. 2017 Dec 1;410:41-49. PubMed PMID: 28951130
Practice Locations
UCHealth Dermatology Clinic - Anschutz Medical Campus1665 Aurora Ct
3rd Floor, Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-0500
Hospital Affiliation
- University of Colorado Hospital
Specialty Information
Specialties- Dermatology, Board Certification (2025)
- Mohs Surgery (2025)
- Cancers
- Cancers - Melanoma
- Cancers - Skin Cancer
- Skin, Hair and Nails - Biopsies and Excisions
- Skin, Hair and Nails
- Surgery - Plastic, Reconstructive and Aesthetic Surgery
- Surgery
- Failed Prior Surgery
Clinical Interests
My main clinic interests include: early detection of melanoma, Mohs for melanoma, reconstruction modalities following skin cancer excision.
Care Philosophy
Since discovering that my family carries a rare gene mutation that significantly increases our risk of developing melanoma, I have dedicated my career to diagnosing and treating skin cancers such as melanoma, basal cell carcinoma, and squamous cell carcinoma. During my training, I became skilled in the early detection of skin cancer, which enables prompt treatment and management. I also completed additional training in Mohs micrographic surgery, a specialized technique known for its excellent cure rates and outstanding cosmetic outcomes, particularly in treating skin cancers on the face and other sensitive areas. Additionally, I have received advanced training in post-skin cancer reconstruction, including skin grafts and flaps. As a result, I am uniquely equipped to guide patients through every step of their melanoma care—from initial diagnosis and treatment to long-term surveillance.
My main clinic interests include: early detection of melanoma, Mohs for melanoma, reconstruction modalities following skin cancer excision.
Care Philosophy
Since discovering that my family carries a rare gene mutation that significantly increases our risk of developing melanoma, I have dedicated my career to diagnosing and treating skin cancers such as melanoma, basal cell carcinoma, and squamous cell carcinoma. During my training, I became skilled in the early detection of skin cancer, which enables prompt treatment and management. I also completed additional training in Mohs micrographic surgery, a specialized technique known for its excellent cure rates and outstanding cosmetic outcomes, particularly in treating skin cancers on the face and other sensitive areas. Additionally, I have received advanced training in post-skin cancer reconstruction, including skin grafts and flaps. As a result, I am uniquely equipped to guide patients through every step of their melanoma care—from initial diagnosis and treatment to long-term surveillance.
Personal Interests
In my spare time, I am an aspiring artisan pizza chef, a recreational soccer league enthusiast, a snowboarder, a Formula 1 fan, and an avid Broncos supporter.
Public Speaking
Yes
In my spare time, I am an aspiring artisan pizza chef, a recreational soccer league enthusiast, a snowboarder, a Formula 1 fan, and an avid Broncos supporter.
Public Speaking
Yes